Nuchev Pty Ltd · ASX:NUC
Nuchev Pty — Shareholder Meeting (November 2022)
20 slides from Nuchev Pty's shareholder meeting presentation, Nov 28, 2022
Slide 1: Annual General Meeting Chair's Address and Executive Presentation
NUCHEV LIMITED (ACN 163 225 090) LEVEL 10, 420 ST KILDA ROAD MELB 3004 WWW.NUCHEV.COM.AU ASX CODE: NUC 28 November 2022 ASX Market Release For personal use only Annual General Meeting Chair’s Address and Executive Presentation Nuchev Limited (ASX: NUC) (“Nuchev” or “the Company”) is pleased to relea
Slide 2: Chair's Address
GPO Box 5193 w: automicgroup.com.au Sydney NSW 2001 Justin Breheny, Chair’s Address Nuchev Ltd AGM | 2.00pm AEDT | 28 November 2022 Introduction While solid progress and repositioning has been achieved in the 2022 financial year, there is no doubt we have encountered challenging market conditions, a
Slide 3: Chair's Address (continued)
GPO Box 5193 w: automicgroup.com.au Sydney NSW 2001 We continue to receive positive endorsement from parents who recognise the health benefits, improved digestion and immunity offered by Oli6®. Capital light, flexible business model, expanding market footprint A critical advantage and enabler to Nuc
Slide 4: Nuchev Limited Annual General Meeting
For personal use only Nuchev Limited Annual General Meeting Monday 28 November 2022
Slide 5: Acknowledgement of Country
Acknowledgement of Country For personal use only I would like to acknowledge the traditional custodians of the land on which our office in St Kilda Road is located, the Wurundjeri People of the Kulin nation, and pay my respects to the Elders, past, present and emerging. Directors and shareholders ar
Slide 6: Board of Directors
Board of Directors For personal use only Justin Breheny Ben Dingle Selina Lightfoot Non-Executive Director and Chair Executive Director and Founder Non-Executive Director Michelle Terry Jeff Martin Owens Chan Non-Executive Director Non-Executive Director Non-Executive Director 2
Slide 7: Also present today
Also present today For personal use only Greg Kerr Mick Myers Chief Executive Officer Chief Financial Officer Tamara Barr Katie Struthers Company Secretary External Auditor 3
Slide 8: Agenda
Agenda For personal use only 1 2 3 4 5 6 FY22 FY23 Shareholder Chair’s Introducing Operational Items of Q1 Update & Questions Address our CEO Overview Business Outlook 4
Slide 9: Chair's Address
Chair’s Address For personal use only Justin Breheny Non-Executive Director and Chair 5
Slide 10: Introducing our CEO
Introducing our CEO For personal use only An extensive background in Consumer Branded business, having led multiple organisations over the last 19 years. Nuchev Limited: CEO (appointed October 2022) Southern Metropolitan Cemeteries Trust: Interim CEO (May – October 2022) 2XU: CEO (November 201
Slide 11: FY22 Operational Overview
FY22 Operational Overview For personal use only Ben Dingle Executive Director and Founder 7
Slide 12: Our Purpose
Our Purpose Food for a better life For personal use only We are committed to improving families’ lives DEMONSTRATED BY Leadership in premium digestion and immunity Backed by science Fuelled by consumer led innovation World class ingredients SUPPORTED THROUGH Premium nutrition Consumer endorsement Go
Slide 13: FY22 Key Impacts
FY22 Key Impacts For personal use only FY22 saw the Group progress whilst continuing to face challenges post COVID-19 with supply chain and demand impacted • CBEC market for infant formula reducing post double 11 2021 CHINA MARKET • Shift from local export to Corporate Daigou in B2C market CORRECTIO
Slide 14: FY22 Key Metrics
Key FY22Metrics Key Metrics For personal use only FY22 FY21 % change Commentary Revenue and volume performance was down 11% and 10%, Volume (MT) 1 332.6 370.2 (10%) respectively Gross margin for Oli6®4 was 37.2%, versus 34.0% in FY21 Revenue ($m) 1 9.7 10.9 (11%) Adjusted EBITDA performance wa
Slide 15: FY22 Financial & Operational Performance
FY22 Financial & Operational Performance For personal use only Volumes (Metric Tonnes1) Positive net cash position of $5.1m with no debt Through disciplined cost control measures and targeted sales initiatives, the Group was able to reduce its net cash consumed in operating activities by $1.2m AU
Slide 16: FY23 Q1 Update & Growth Strategy
FY23 Q1 Update & Growth Strategy For personal use only Greg Kerr Chief Executive Officer 12
Slide 17: FY23 Q1 Update
FY23 Q1 Q1 FY23 Update Update For personal use only Expanding sales in Australian Grocery CBEC remains challenging Oli6® was the fastest growing Goat Milk Infant Formula brand in CBEC remains highly competitive, and margin challenged Coles quarter on quarter (“QoQ”) Nuchev has reset strategy a
Slide 18: Growth Strategy
Growth Item 1Strategy For personal use only 14
Slide 19: Food for a better life
better life food for a > 0) €@- r O =} c Ajuo eSn feuosied JOS
Slide 20: Disclaimer
Disclaimer For personal use only This presentation is provided by Nuchev Limited (ACN 163 225 090) (Nuchev) to provide summary information about Nuchev and its respective subsidiaries (together, the Group). Statements in this presentation are made as at the date of the presentation and the informati